Axxam at Bio-IT World Conference & Expo 2025 – Transforming Drug Discovery with Data & Technology

Axxam is excited to participate in Bio-IT World Conference & Expo 2025, a leading event at the intersection of life sciences, AI, and data-driven innovation. This conference brings together experts in bioinformatics, computational biology, and digital transformation, showcasing the latest advancements in AI-powered drug discovery, high-performance computing, and data management.

Our team will join industry leaders, researchers, and technology pioneers to explore how cutting-edge informatics and automation are shaping the future of biopharmaceutical research and early-stage drug discovery. With a strong foundation in high-throughput screening (HTS), advanced assay development, and data-driven decision-making, Axxam is committed to leveraging technology to accelerate the discovery of novel therapeutics.

We specialize in target-based and phenotypic screening, compound profiling, and functional genomics, working across key therapeutic areas such as oncology, neuroscience, and metabolic disorders. By integrating AI-enhanced analytics, machine learning, and high-content imaging, we provide actionable insights that drive smarter drug development.

The Bio-IT World Conference & Expo is an excellent opportunity to connect with biotech innovators, pharmaceutical partners, and data scientists to discuss the latest trends in computational drug discovery, digital biopharma, and cloud-based research solutions. If you’re attending, let’s explore how Axxam’s expertise in integrating technology and life sciences can support your research goals. Stay tuned for updates from the event!